Company Overview and News
Mumbai: The Hinduja Group flagship, Chennai-based Ashok Leyland, plans to redesign its light commercial vehicles (LCVs) to serve the fast-growing Indian e-commerce industry’s last-mile delivery needs, according to a senior company executive.
Hinduja Group flagship Ashok Leyland has chalked out a Rs 1000 crore plan for 2018-19 which include setting up of a factory in Andhra Pradesh, a top company official said today.
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Ashok Leyland, the country’s third biggest truck and bus maker, will spend Rs 1000 crore as capital expenditure, launch 30 products to further improve its performance, a top company executive said.
The Indian equity market was trading on a positive note on Monday afternoon with the Nifty adding 33 points and was trading above the 10,500 mark at 10,513 while the Sensex was up 95 points or 0.28 percent.
The Indian equity market was trading on a negative note on Monday afternoon with the Nifty shedding 12 points and was trading just below the 10,500 mark at 10,468 while the Sensex was down 71 points or 0.21 percent.
The Indian equity market was trading on a negative note on Monday morning with the Nifty shedding 13 points and was trading just below the 10,500 mark at 10,467 while the Sensex was down 57 points or 0.17 percent.
Mumbai: The rupee recovered 5 paise from its early losses against the greenback in late morning deals following bouts of dollar selling from banks and exporters amid higher local equities.
New Delhi:) Hinduja flagship firm Ashok Leyland today said it has bagged contract from Ministry of Defence (MoD) for supplying High Mobility 10×10 vehicles (HMV 10×10) to carry Smerch Rockets, with an initial order worth over Rs 100 crore.
Shares of Ashok Leyland ended higher by over 3 per cent as the company has won a contract from the Defence Ministry for supplying high mobility vehicles.
3:30 pm Market at Close: Shares have ended the day and week on a positive note, with the Nifty closing near 10,500-mark.
2:45 pm OMCs in focus: Oil retailers declined after Brent crude oil futures started moving towards USD 73 a barrel.
1:47 pm Market Update: The market gained strength against in afternoon as technology stocks and Reliance Industries continued to support, but the selling pressure select banks capped upside.
The Indian equity market continued trading on a positive note on Friday afternoon with the Nifty adding 33 points and was trading just below the 10,500 mark at 10,491 while the Sensex was up 126 points or 0.37 percent.
12:51 pm Market Update: The market continued to trade higher for the seventh consecutive session after macro data. Investors await Infosys earnings.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...